P53 Mutation Analysis to Predict Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer

doi 10.21236/ada420856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

99mTc-Sestamibi Scintigraphy Used to Evaluate Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Quantitative Analysis

Oncology Letters
Cancer ResearchOncology
2010English

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static Versus Kinetic Measures of Fluorodeoxyglucose Uptake

Clinical Cancer Research
Cancer ResearchOncology
2011English

Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Barriers to Treatment in Patients With Locally Advanced Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Neoadjuvant Treatment Strategy for Locally Advanced Thoracic Esophageal Cancer

Annals of Gastroenterological Surgery
2019English

Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer

Genetic Testing and Molecular Biomarkers
MedicineGenetics
2012English

Gene Expression Profiles Do Not Consistently Predict the Clinical Treatment Response in Locally Advanced Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Neoadjuvant Radiotherapy in the Approach of Locally Advanced Breast Cancer

ESMO Open
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy